➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Harvard Business School
AstraZeneca
Merck

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

TETRACAINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Tetracaine Hydrochloride patents expire, and what generic alternatives are available?

Tetracaine Hydrochloride is a drug marketed by Alcon Labs and Bausch Lomb Ireland and is included in two NDAs.

The generic ingredient in TETRACAINE HYDROCHLORIDE is tetracaine hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tetracaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tetracaine Hydrochloride

A generic version of TETRACAINE HYDROCHLORIDE was approved as tetracaine hydrochloride by ALCON LABS on February 29th, 2016.

  Free Forever Trial

Summary for TETRACAINE HYDROCHLORIDE
Drug patent expirations by year for TETRACAINE HYDROCHLORIDE
Recent Clinical Trials for TETRACAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Our Lady of the Lake HospitalEarly Phase 1
Louisiana State University Health Sciences Center - New OrleansEarly Phase 1
Mayo ClinicPhase 2/Phase 3

See all TETRACAINE HYDROCHLORIDE clinical trials

Pharmacology for TETRACAINE HYDROCHLORIDE
Drug ClassEster Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for TETRACAINE HYDROCHLORIDE

US Patents and Regulatory Information for TETRACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 208135-001 Feb 29, 2016 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Bausch Lomb Ireland TETRACAINE HYDROCHLORIDE tetracaine hydrochloride SOLUTION;OPHTHALMIC 210821-001 Mar 12, 2019 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Harvard Business School
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.